Avail our expert fertility specialists’ opinion for free.
You can send us a WhatsApp message on +91 90812 33800 and chat with our specialist.
Ovarian hyperstimulation syndrome (OHSS) is a side effect of fertility medication that involves using pharmacological substances to promote ovarian stimulation to increase the number of oocytes and thus the number of embryos accessible during assisted reproductive technology (ART).
The ovarian response exceeds that goal in a small percentage of female patients undergoing IVF treatment in Ahmedabad, resulting in clinical diseases with distinct aetiology. The most severe side-effect of ovulation induction is ovarian hyperstimulation syndrome (OHSS). It causes a wide range of symptoms.
In women undergoing assisted reproduction, it manifests as an increased reaction to ovulation induction. The risk of OHSS differs depending on the type of fertility approach used, with therapies involving higher levels of ovarian stimulation having a higher risk.
Now, let’s know,
Clinical criteria are used to make the diagnosis. Fertility specialists use clinical symptoms, ultrasound findings, and laboratory markers to classify OHSS into different phases and grades. So, having a distribution based on symptoms is critical.
In a fertility clinic in Ahmedabad, mild and moderate ovarian hyperstimulation syndrome can be treated promptly in an outpatient setting. The specialist can hospitalize patients with severe OHSS to an ICU.
Fortunately, severe OHSS is quite rare when using advanced treatment procedures. So, early detection and timely evaluation and treatment of patients with moderate or severe OHSS are fundamental concepts of OHSS management.
Early: After 5 to 7 days of taking the hCG trigger shot.
Late: After detection of pregnancy, it is observed.
Now, let’s know,
OHSS signs and symptoms are divided into three categories based on their severity:
Now, let’s discuss,
Following the trigger shot to encourage final follicular maturation before oocyte retrieval, the average patient has stomach distension and discomfort.
There may have been a previous record of an extreme ovarian stimulation response, but this does not rule out an analysis of OHSS.
Patients are divided into two categories based on when they present after receiving the trigger injection:
These women’s ovarian responses may be ordinary at first. Early OHSS occurs within seven days of receiving the hCG shot. It is frequently linked with an overactive ovarian response.
Endogenous hCG produced from early pregnancy is usually the cause of late OHSS. It appears within or more than ten days after the hCG shot. Late OHSS is more severe and lasts longer than the earlier variant.
Take a complete medical history of a patient suspected of having OHSS.
Examining dehydration and edema (vulval, pedal, and sacral). Recording the heart rate, blood pressure, breathing rate, and weight.
Examine ascites, peritonism, palpable mass, and girth.
Determine whether there is pneumonia, pleural effusion, or pulmonary edema.